Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Novo Nordisk's high dose Wegovy (semaglutide) has shown improved weight loss while remaining safe and tolerable.

“Taking these medications puts individuals at risk of everything from allergic reactions to uncontrolled blood sugar levels, ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Novo Nordisk (NVO) stock slipped after ate-stage trial data for a higher-dose version of its popular obesity therapy, ...

Mounjaro, like other GLP-1 drugs, carries potential side effects, including nausea, vomiting, dehydration, and hypoglycaemia ...

According to NVO, the 7.2 mg version was safe and had a well-tolerated profile ... in addition to the health benefits already established with Wegovy,” said Martin Holst Lange, NVO’s executive ...

While it's illegal to sell certain substances without a prescription, it's possible that you could be sold fake weight loss ...

The late-stage trial of semaglutide, which it markets as Wegovy to treat obesity ... the higher dose appeared to have a safe and well-tolerated profile, consistent with other drugs of the same ...

International Community Health Services (ICHS) has launched Together We Rise, a wellness podcast with useful information ...